India's Biocon expects oral insulin partner by March

Status
Not open for further replies.

Northerner

Admin (Retired)
Relationship to Diabetes
Type 1
Biocon Ltd (BION.NS), India's largest listed biotechnology company, expects to find a deep-pocketed global partner for its experimental oral insulin pill by end-March, its top executive said on Wednesday.

"We are in advanced discussions with potential partners," Biocon's Managing Director Kiran Mazumdar-Shaw told the Reuters India Investment Summit in Bangalore.

http://www.reuters.com/article/2011/11/23/us-india-summit-biocon-idUSTRE7AM0MO20111123
 
Status
Not open for further replies.
Back
Top